Renuvion Safely and Effectively Treats Lax Skin in Trial
In a Phase II study, the Renuvion device improved the appearance of lax skin in 82.5% of subjects after 6 months.
In a Phase II study, the Renuvion device improved the appearance of lax skin in 82.5% of subjects after 6 months.
A new ISAPS report shows a facial procedure has overtaken liposuction as the most-performed surgery worldwide.
A study finds patients with a history of COVID had higher rates of venous thromboembolism following panniculectomy, even with standard clot prevention.